Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pearson

Showing results (1091-1100 of 1,112) with videos related to

Pageof 112
Sort By:
Diabetes Care|December 16, 2020
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT StudyRoberto Bizzotto, Christopher Jennison, Angus G Jones, et al.
Nature Genetics|December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, , Kaixin Zhou, et al.
Communications Biology|August 11, 2022
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like proteaseVasundara Srinivasan, Hévila Brognaro, Prince R Prabhu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.
Nature Genetics|August 9, 2016
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metforminKaixin Zhou, Sook Wah Yee, Eric L Seiser, et al.
Diabetes Care|September 27, 2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic DiabetesDiana L Cousminer, Emma Ahlqvist, Rajashree Mishra, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
Diabetes|May 12, 2017
A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes VariantsAndrew R Wood, Anna Jonsson, Anne U Jackson, et al.
Nature Communications|August 21, 2023
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traitsAndrew A Brown, Juan J Fernandez-Tajes, Mun-Gwan Hong, et al.
Metabolism: Clinical and Experimental|February 8, 2026
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosisNatalie N Atabaki, Daniel E Coral, Hugo Pomares-Millan, et al.
Pageof 112

Showing results (1091-1100 of 1,112) with videos related to

Sort By:
Pageof 112
Diabetes Care|December 16, 2020
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT StudyRoberto Bizzotto, Christopher Jennison, Angus G Jones, et al.
Nature Genetics|December 28, 2010
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, , Kaixin Zhou, et al.
Communications Biology|August 11, 2022
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like proteaseVasundara Srinivasan, Hévila Brognaro, Prince R Prabhu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.
Nature Genetics|August 9, 2016
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metforminKaixin Zhou, Sook Wah Yee, Eric L Seiser, et al.
Diabetes Care|September 27, 2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic DiabetesDiana L Cousminer, Emma Ahlqvist, Rajashree Mishra, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
Diabetes|May 12, 2017
A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes VariantsAndrew R Wood, Anna Jonsson, Anne U Jackson, et al.
Nature Communications|August 21, 2023
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traitsAndrew A Brown, Juan J Fernandez-Tajes, Mun-Gwan Hong, et al.
Metabolism: Clinical and Experimental|February 8, 2026
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosisNatalie N Atabaki, Daniel E Coral, Hugo Pomares-Millan, et al.
Pageof 112